Literature DB >> 24662787

Influence of betulin and 28-O-propynoylbetulin on proliferation and apoptosis of human melanoma cells (G-361).

Arkadiusz Orchel1, Anna Kulczycka1, Ewa Chodurek1, Ewa Bębenek2, Paulina Borkowska3, Stanisław Boryczka2, Jan Kowalski3, Zofia Dzierżewicz1.   

Abstract

INTRODUCTION: Pentacyclic triterpenes are a group of compounds known to have anticancer activity. One of the best characterized triterpenes is betulin, which can be isolated from bark of birch trees and modified into new compounds with various interesting medical properties. Betulin is involved in activation of the caspase cascade and promotes cell death. The aim of the study was to investigate the effect of betulin and its acetylenic derivative, 28-O-propynoylbetulin, on proliferation and apoptosis in a human melanoma cell line.
MATERIALS AND METHODS: The G-361 melanoma cell line was used. To evaluate growth arrest and caspase-3 activity, cells were treated with betulin and its derivative at a wide range of concentrations from 0.1 to 10 μg/mL.
RESULTS: Betulin and 28-O-propynoylbetulin inhibited cell proliferation in a concentration-dependent manner. The cell cycle analysis revealed an increase of the sub-G1 cell fraction (representing dead cells) after incubation of cells with betulin and 28-O-propynoylbetulin. The observed cytotoxic effects were more pronounced for 28-O-propynoylbetulin. Activity of caspase-3 in 28-O-propynoylbetulin treated cells was nearly 2-fold greater compared to cells incubated with betulin. DISCUSSION: Our results show that betulin and 28-O-propynoylbetulin were effective in inhibition of cell growth and induction of apoptosis in a human melanoma cell line. The addition of the propynoyl group at the C-28 hydroxyl group of betulin led to a greater proapoptotic and antiproliferative effect in comparison to unmodified betulin. These observations suggest that the obtained derivative is a potent anti-melanoma agent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662787     DOI: 10.5604/17322693.1088757

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  9 in total

1.  Antitumor Activity of Betulinic Acid and Betulin in Canine Cancer Cell Lines.

Authors:  Jing Zhao; Rongfang Li; Aleksandra Pawlak; Marta Henklewska; Angelika Sysak; Lixin Wen; Jin-E Yi; Bożena Obmińska-Mrukowicz
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

Review 2.  New acetylenic derivatives of betulin and betulone, synthesis and cytotoxic activity.

Authors:  Ewa Bębenek; Monika Kadela-Tomanek; Elwira Chrobak; Joanna Wietrzyk; Joanna Sadowska; Stanisław Boryczka
Journal:  Med Chem Res       Date:  2016-09-01       Impact factor: 1.965

3.  Anticancer properties of ester derivatives of betulin in human metastatic melanoma cells (Me-45).

Authors:  Małgorzata Drąg-Zalesińska; Marcin Drąg; Marcin Poręba; Sylwia Borska; Julita Kulbacka; Jolanta Saczko
Journal:  Cancer Cell Int       Date:  2017-01-03       Impact factor: 5.722

4.  Lup-20(29)-en-3β,28-di-yl-nitrooxy acetate affects MCF-7 proliferation through the crosstalk between apoptosis and autophagy in mitochondria.

Authors:  Xiaoning Yan; Lei Yang; Gaili Feng; Zhuli Yu; Minjie Xiao; Weibin Cai; Yanmei Xing; Shasha Bai; Junqia Guo; Zhiyu Wang; Tao Wang; Rong Zhang
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

5.  Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.

Authors:  Justyna Kutkowska; Leon Strzadala; Andrzej Rapak
Journal:  Cancer Sci       Date:  2017-09-19       Impact factor: 6.716

6.  Anticancer Activity of the Acetylenic Derivative of Betulin Phosphate Involves Induction of Necrotic-Like Death in Breast Cancer Cells In Vitro.

Authors:  Arkadiusz Orchel; Ewa Chodurek; Marzena Jaworska-Kik; Piotr Paduszyński; Anna Kaps; Elwira Chrobak; Ewa Bębenek; Stanisław Boryczka; Paulina Borkowska; Janusz Kasperczyk
Journal:  Molecules       Date:  2021-01-25       Impact factor: 4.411

7.  Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines.

Authors:  Sylwia K Król; Ewa Bębenek; Magdalena Dmoszyńska-Graniczka; Adrianna Sławińska-Brych; Stanisław Boryczka; Andrzej Stepulak
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

8.  The Cytotoxic Effects of Betulin-Conjugated Gold Nanoparticles as Stable Formulations in Normal and Melanoma Cells.

Authors:  Marius Mioc; Ioana Zinuca Pavel; Roxana Ghiulai; Dorina E Coricovac; Claudia Farcaş; Ciprian-Valentin Mihali; Camelia Oprean; Vlad Serafim; Ramona A Popovici; Cristina A Dehelean; Michael I Shtilman; Aristidis M Tsatsakis; Codruţa Şoica
Journal:  Front Pharmacol       Date:  2018-05-03       Impact factor: 5.810

9.  Novel Triazole Hybrids of Betulin: Synthesis and Biological Activity Profile.

Authors:  Ewa Bębenek; Maria Jastrzębska; Monika Kadela-Tomanek; Elwira Chrobak; Beata Orzechowska; Katarzyna Zwolińska; Małgorzata Latocha; Anna Mertas; Zenon Czuba; Stanisław Boryczka
Journal:  Molecules       Date:  2017-11-01       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.